Alithea Biotechnology GmbH
PrivateLast Round
Seed
Jun 23, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alithea Biotechnology GmbH operates in Healthcare & Life Sciences and is based in Freiburg. It was founded in 2019.
Alithea Biotechnology GmbH is a biotechnology company that provides immunopeptidomics research services, AI-driven target discovery, and a proprietary HLA peptide database to support the development of precision immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alithea Biotechnology GmbH Comparables
Compare Alithea Biotechnology GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pure MHC, LLC | 78% | |
| Bruker | 71% | |
| ProImmune Ltd | 69% |
For institutional investors. Book with your work email.
Alithea Biotechnology GmbH Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 220% MoM, reaching 1.6K.
- Jun 22, 2026
Monthly visitors increased 61% MoM.
For institutional investors. Book with your work email.
Alithea Biotechnology GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alithea Biotechnology GmbH's valuation, stock price, and market status.
Is Alithea Biotechnology GmbH a public or private company?
Alithea Biotechnology GmbH is a private company.
What is the current stock price of Alithea Biotechnology GmbH?
Alithea Biotechnology GmbH is a private company, so its shares have no public market price. Caplight tracks Alithea Biotechnology GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alithea Biotechnology GmbH worth (valuation)?
Valuation information for Alithea Biotechnology GmbH is not publicly available.
Can I buy Alithea Biotechnology GmbH stock?
Alithea Biotechnology GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alithea Biotechnology GmbH's last funding round?
Alithea Biotechnology GmbH's most recent funding round was Seed on June 23, 2026.
Who are the main investors in Alithea Biotechnology GmbH?
Investor information for Alithea Biotechnology GmbH is not publicly disclosed.
Will Alithea Biotechnology GmbH IPO soon?
No public IPO plans have been announced for Alithea Biotechnology GmbH.
How can I track Alithea Biotechnology GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Alithea Biotechnology GmbH's shares on secondary markets.